Cargando…
Tumour-Agnostic Therapy for Pancreatic Cancer and Biliary Tract Cancer
The prognosis of patients with solid tumours has remarkably improved with the development of molecular-targeted drugs and immune checkpoint inhibitors. However, the improvements in the prognosis of pancreatic cancer and biliary tract cancer is delayed compared to other carcinomas, and the 5-year sur...
Autor principal: | Kato, Shunsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914923/ https://www.ncbi.nlm.nih.gov/pubmed/33562094 http://dx.doi.org/10.3390/diagnostics11020252 |
Ejemplares similares
-
Tumour-agnostic drugs in paediatric cancers
por: Chisholm, Julia C., et al.
Publicado: (2020) -
Reply to ‘Comment on “Tumour-agnostic drugs in paediatric cancers”’
por: Chisholm, Julia C., et al.
Publicado: (2020) -
Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011) -
Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023) -
Clinical characteristics of pancreatic and biliary tract cancers associated with Lynch syndrome
por: Takamizawa, Shigemasa, et al.
Publicado: (2021)